Aveva Drug Delivery Systems is pleased to announce that it will be exhibiting at the 39th Annual Meeting and Exposition of the Controlled Release Society, which is being held from 15 until 18 July 2012 in Quebec, Canada.
Aveva is a global leader in transdermal drug delivery, located in the US. The company has an extensive history of providing pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. By leveraging this experience, Aveva offers a full range of research, development and manufacturing capabilities to produce transdermal pharmaceutical products that can improve the quality of life, usage and compliance rates for patients.
Visit the company at booth number 309, or contact Ms Hitomi Mizugaki at hitomi.mizugaki@avevadds.com to schedule a meeting in advance.